ImmuPharma plc (AIM: IMM)
London
· Delayed Price · Currency is GBP · Price in GBX 2.822
-0.258 (-8.39%)
Jan 22, 2025, 12:10 PM GMT+1
ImmuPharma Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | -0.07 | - | - | 0.12 | 0.13 | 0.08 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | -6.57% | 62.55% | -4.13% | Upgrade
|
| Gross Profit | -0.07 | - | - | 0.12 | 0.13 | 0.08 | Upgrade
|
| Selling, General & Admin | 0.87 | 1.02 | 0.85 | 1.01 | 1.76 | 1.83 | Upgrade
|
| Research & Development | 1.67 | 2.02 | 2.02 | 3.65 | 2.37 | 2.66 | Upgrade
|
| Other Operating Expenses | -0.12 | -0.12 | - | - | - | -0.12 | Upgrade
|
| Operating Expenses | 2.46 | 3.06 | 3.03 | 5.28 | 5.72 | 6.36 | Upgrade
|
| Operating Income | -2.53 | -3.06 | -3.03 | -5.16 | -5.59 | -6.28 | Upgrade
|
| Interest Expense | -0 | -0 | -0 | -0.12 | -0.23 | -0 | Upgrade
|
| Interest & Investment Income | 0.01 | 0 | 0 | 0 | 0.04 | 0.01 | Upgrade
|
| Currency Exchange Gain (Loss) | -0 | -0 | -0.02 | 0 | -0.15 | -0.52 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.35 | -0.35 | -1.41 | -2.23 | -1.32 | 0.06 | Upgrade
|
| EBT Excluding Unusual Items | -2.88 | -3.42 | -4.46 | -7.51 | -7.25 | -6.74 | Upgrade
|
| Other Unusual Items | - | - | - | -1.43 | - | - | Upgrade
|
| Pretax Income | -2.88 | -3.42 | -4.46 | -8.94 | -7.25 | -6.74 | Upgrade
|
| Income Tax Expense | -0.41 | -0.5 | -0.65 | -0.77 | -0.39 | -0.62 | Upgrade
|
| Net Income | -2.46 | -2.92 | -3.81 | -8.17 | -6.86 | -6.12 | Upgrade
|
| Net Income to Common | -2.46 | -2.92 | -3.81 | -8.17 | -6.86 | -6.12 | Upgrade
|
| Shares Outstanding (Basic) | 404 | 362 | 303 | 251 | 200 | 153 | Upgrade
|
| Shares Outstanding (Diluted) | 404 | 362 | 303 | 251 | 200 | 153 | Upgrade
|
| Shares Change (YoY) | 23.36% | 19.51% | 20.60% | 25.47% | 30.45% | 10.52% | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.03 | -0.03 | -0.04 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.03 | -0.03 | -0.04 | Upgrade
|
| Free Cash Flow | -1.59 | -1.36 | -2.45 | -4.88 | -3.69 | -4.33 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.02 | -0.02 | -0.03 | Upgrade
|
| Gross Margin | - | - | - | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | - | - | - | -4359.84% | -4412.70% | -8061.14% | Upgrade
|
| Profit Margin | - | - | - | -6906.55% | -5415.72% | -7858.31% | Upgrade
|
| Free Cash Flow Margin | - | - | - | -4126.83% | -2912.91% | -5554.70% | Upgrade
|
| EBITDA | -2.56 | -3.03 | -2.91 | -5.05 | -5.42 | -6.19 | Upgrade
|
| D&A For EBITDA | -0.03 | 0.04 | 0.12 | 0.11 | 0.17 | 0.09 | Upgrade
|
| EBIT | -2.53 | -3.06 | -3.03 | -5.16 | -5.59 | -6.28 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.